Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study

2000 ◽  
Vol 66 (1) ◽  
pp. 23-27 ◽  
Author(s):  
John M. Bennett ◽  
Mary S. Young ◽  
Jane L. Liesveld ◽  
Elisabeth Paietta ◽  
Kenneth B. Miller ◽  
...  
Keyword(s):  
High Risk ◽  
Phase Ii ◽  
Myelodysplastic Syndromes ◽  
Phase Ii Study ◽  
Eastern Cooperative Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Gm Csf ◽  
Intermediate Dose

A feasibility and phase II study of the hu14.18-IL2 immunocytokine in combination with GM-CSF and isotretinoin in patients with recurrent or refractory neuroblastoma: A Children’s Oncology Group study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 10017-10017 ◽  
Author(s):  
Suzanne Shusterman ◽  
Wendy B. London ◽  
Jacquelyn A Hank ◽  
Marguerite T Parisi ◽  
Barry L. Shulkin ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Gm Csf

A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)

Oncology ◽  
2000 ◽  
Vol 58 (3) ◽  
pp. 215-218 ◽  
Author(s):  
Jordan D. Berlin ◽  
Sudeshna Adak ◽  
David J. Vaughn ◽  
David Flinker ◽  
Lawrence Blaszkowsky ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Eastern Cooperative Oncology Group ◽  
Metastatic Pancreatic Cancer ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document